BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCluggage WG. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? J Clin Pathol. 2002;55:321-325. [PMID: 11986333 DOI: 10.1136/jcp.55.5.321] [Cited by in Crossref: 235] [Cited by in F6Publishing: 198] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Verma M, Joseph G, Mccluggage WG. Uterine Composite Tumor Composed of Leiomyosarcoma and Embryonal Rhabdomyosarcoma With Immature Cartilage: . International Journal of Gynecological Pathology 2009;28:338-42. [DOI: 10.1097/pgp.0b013e3181942a4f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Djordjevic B, Gien L, Covens A, Malpica A, Khalifa M. Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma. Gynecologic Oncology 2009;115:32-6. [DOI: 10.1016/j.ygyno.2009.06.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Vitale SG, Laganà AS, Capriglione S, Angioli R, La Rosa VL, Lopez S, Valenti G, Sapia F, Sarpietro G, Butticè S, Tuscano C, Fanale D, Tropea A, Rossetti D. Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives. Int J Mol Sci 2017;18:E1100. [PMID: 28531111 DOI: 10.3390/ijms18051100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
4 Thariat J, Marcy PY. Carcinosarcomas of the uterus should no longer be analyzed with uterine sarcomas. In reply to S. Sampath et al. (Int J Radiat Oncol Biol Phys, 2010;76:728-734). Int J Radiat Oncol Biol Phys 2010;77:1605. [PMID: 20637984 DOI: 10.1016/j.ijrobp.2010.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Moukarzel LA, Ferrando L, Da Cruz Paula A, Brown DN, Geyer FC, Pareja F, Piscuoglio S, Papanastasiou AD, Fusco N, Marchiò C, Abu-Rustum NR, Murali R, Brogi E, Wen HY, Norton L, Soslow RA, Vincent-Salomon A, Reis-Filho JS, Weigelt B. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas. Mol Oncol 2021;15:1024-39. [PMID: 33021035 DOI: 10.1002/1878-0261.12813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K, Oliva E, Parkash V, Rutgers JKL, Staats PN, Stewart CJR, Tornos C, Soslow RA. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations. Int J Gynecol Pathol 2019;38 Suppl 1:S40-63. [PMID: 30550483 DOI: 10.1097/PGP.0000000000000491] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 17.7] [Reference Citation Analysis]
7 Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol. 2011;25:681-689. [PMID: 21816678 DOI: 10.1016/j.bpobgyn.2011.07.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
8 Luong TMH, Akazawa Y, Mussazhanova Z, Matsuda K, Ueki N, Miura S, Hara T, Yokoyama H, Nakashima M. Cutaneous pilomatrical carcinosarcoma: a case report with molecular analysis and literature review. Diagn Pathol 2020;15:7. [PMID: 32005258 DOI: 10.1186/s13000-020-0925-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Loh TL, Tomlinson J, Chin R, Eslick GD. Cutaneous carcinosarcoma with metastasis to the parotid gland. Case Rep Otolaryngol 2014;2014:173235. [PMID: 25328737 DOI: 10.1155/2014/173235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Okabayashi T, Shima Y, Iwata J, Iiyama T, Sumiyoshi T, Kozuki A, Tokumaru T, Hata Y, Noda Y, Morita M. Surgical outcomes for 131 cases of carcinosarcoma of the hepatobiliary tract. J Gastroenterol. 2014;49:982-991. [PMID: 24162331 DOI: 10.1007/s00535-013-0882-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
11 Artioli G, Wabersich J, Ludwig K, Gardiman MP, Borgato L, Garbin F. Rare uterine cancer: Carcinosarcomas. Review from histology to treatment. Critical Reviews in Oncology/Hematology 2015;94:98-104. [DOI: 10.1016/j.critrevonc.2014.10.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
12 Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 2009;54:355-64. [PMID: 19236512 DOI: 10.1111/j.1365-2559.2009.03231.x] [Cited by in Crossref: 256] [Cited by in F6Publishing: 212] [Article Influence: 19.7] [Reference Citation Analysis]
13 Samarnthai N, Hall K, Yeh IT. Molecular profiling of endometrial malignancies. Obstet Gynecol Int 2010;2010:162363. [PMID: 20368795 DOI: 10.1155/2010/162363] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 5.8] [Reference Citation Analysis]
14 Aviram R, Ochshorn Y, Markovitch O, Fishman A, Cohen I, Altaras MM, Tepper R. Uterine sarcomas versus leiomyomas: Gray-scale and Doppler sonographic findings. J Clin Ultrasound 2005;33:10-3. [DOI: 10.1002/jcu.20075] [Cited by in Crossref: 64] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
15 Saegusa M, Hashimura M, Kuwata T, Okayasu I. Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug. Am J Pathol. 2009;174:2107-2115. [PMID: 19389926 DOI: 10.2353/ajpath.2009.081018] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 5.8] [Reference Citation Analysis]
16 Reed NS, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, Tateo S, Franchi M, Jobsen JJ, Coens C, Teodorovic I, Vergote I, Vermorken JB; European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 2008;44:808-18. [PMID: 18378136 DOI: 10.1016/j.ejca.2008.01.019] [Cited by in Crossref: 336] [Cited by in F6Publishing: 265] [Article Influence: 24.0] [Reference Citation Analysis]
17 Maru Y, Tanaka N, Tatsumi Y, Nakamura Y, Itami M, Hippo Y. Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition. Oncogenesis 2021;10:46. [PMID: 34172714 DOI: 10.1038/s41389-021-00337-8] [Reference Citation Analysis]
18 Inoue H, Takahashi H, Hashimura M, Eshima K, Akiya M, Matsumoto T, Saegusa M. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma. BMC Cancer 2016;16:53. [PMID: 26841870 DOI: 10.1186/s12885-016-2090-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
19 Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, Schultz V, Hui P, Schwartz PE, Rutherford TJ, Weidhaas JB. MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol 2010;118:251-7. [PMID: 20542546 DOI: 10.1016/j.ygyno.2010.05.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
20 Ren CE, Zhu X, Li J, Lyle C, Dowdy S, Podratz KC, Byck D, Chen HB, Jiang SW. Microarray analysis on gene regulation by estrogen, progesterone and tamoxifen in human endometrial stromal cells. Int J Mol Sci 2015;16:5864-85. [PMID: 25782154 DOI: 10.3390/ijms16035864] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
21 Koussidis GA, Douridas IA, Sotiropoulou M, Kioses E. Pathogenesis and origin of extragenital Müllerian carcinosarcoma: evident or still vague? J Obstet Gynaecol 2013;33:427. [PMID: 23654339 DOI: 10.3109/01443615.2013.773296] [Reference Citation Analysis]
22 Felix AS, Scott McMeekin D, Mutch D, Walker JL, Creasman WT, Cohn DE, Ali S, Moore RG, Downs LS, Ioffe OB, Park KJ, Sherman ME, Brinton LA. Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial. Gynecol Oncol 2015;139:70-6. [PMID: 26341710 DOI: 10.1016/j.ygyno.2015.08.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
23 Ko M, Jeng C, Huang S, Shen J, Tzeng C, Chen S. Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature. Acta Oncologica 2009;44:756-60. [DOI: 10.1080/02841860500252016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kahramanoglu I, Demirkiran F, Turan H, Bese T, Cebi S, Ilvan S, Arvas M. Adjuvant Treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma. J Obstet Gynaecol Can 2021;43:34-42. [PMID: 33041218 DOI: 10.1016/j.jogc.2020.06.021] [Reference Citation Analysis]
25 Chittari K, Birnie AJ, Kulkarni KR, Perks AG, Varma S. Sarcomatoid carcinoma of the hand: a clinical case with an aggressive and uncommon presentation. Clin Exp Dermatol 2012;37:505-8. [PMID: 22439885 DOI: 10.1111/j.1365-2230.2011.04277.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
26 Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB, Weinstein JN, Zhang J, Akbani R, Levine DA; Cancer Genome Atlas Research Network. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell 2017;31:411-23. [PMID: 28292439 DOI: 10.1016/j.ccell.2017.02.010] [Cited by in Crossref: 154] [Cited by in F6Publishing: 151] [Article Influence: 30.8] [Reference Citation Analysis]
27 Mccluggage WG. Miscellaneous disorders involving the endometrium. Seminars in Diagnostic Pathology 2010;27:287-310. [DOI: 10.1053/j.semdp.2010.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
28 Gotoh O, Kiyotani K, Chiba T, Sugiyama Y, Takazawa Y, Nemoto K, Kato K, Tanaka N, Nomura H, Hasegawa K, Fujiwara K, Takamatsu S, Matsumura N, Noda T, Mori S. Immunogenomic landscape of gynecologic carcinosarcoma. Gynecol Oncol 2021;160:547-56. [PMID: 33298310 DOI: 10.1016/j.ygyno.2020.11.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Podoll MB, Moghadamfalahi M, Faber E, Bishop JA, Alatassi H. Sarcomatous Component in Uterine Carcinosarcomas Correlates With Advanced Stage and Poorer Prognosis. Int J Gynecol Pathol 2018;37:22-6. [PMID: 28319572 DOI: 10.1097/PGP.0000000000000374] [Reference Citation Analysis]
30 Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol 2012;51:694-705. [PMID: 22793037 DOI: 10.3109/0284186X.2012.689111] [Cited by in Crossref: 88] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
31 Kobayashi H, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Koike N, Shigetomi H. The biology of uterine sarcomas: A review and update. Mol Clin Oncol 2013;1:599-609. [PMID: 24649216 DOI: 10.3892/mco.2013.124] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
32 Ferrandina G, Carbone A, Zannoni GF, Martinelli E, Testa AC, Gallotta V, De Ninno M, Scambia G. Serous ovarian carcinoma recurring as a heterologous carcinosarcoma. J Obstet Gynaecol Res 2007;33:95-9. [DOI: 10.1111/j.1447-0756.2007.00488.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
33 Li Y, Cui L, Chen Y, Wang F. Carcinosarcoma and sarcomatoid carcinoma of the stomach: Two case reports. Medicine (Baltimore) 2021;100:e24697. [PMID: 33761637 DOI: 10.1097/MD.0000000000024697] [Reference Citation Analysis]
34 Akbari A, Khalili N, Asef-Kabiri L, Negahi A, Raeisi A, Akbari ME. Incidence patterns of gynecological sarcomas in Iran analysis of National Cancer Registry data between 2009 and 2014. J Obstet Gynaecol Res 2020. [PMID: 33029884 DOI: 10.1111/jog.14514] [Reference Citation Analysis]
35 Wang JP, Yao ZG, Sun YW, Liu XH, Sun FK, Lin CH, Ren FX, Lv BB, Zhang SJ, Wang Y, Meng FY, Zheng SZ, Gong W, Liu J. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma. World J Gastroenterol 2020; 26(29): 4327-4342 [PMID: 32848337 DOI: 10.3748/wjg.v26.i29.4327] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Näyhä V, Stenbäck F. Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas. APMIS 2008;116:107-17. [PMID: 18321361 DOI: 10.1111/j.1600-0463.2008.00757.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kato S, Espinoza N, Lange S, Villalón M, Cuello M, Owen GI. Characterization and phenotypic variation with passage number of cultured human endometrial adenocarcinoma cells. Tissue Cell 2008;40:95-102. [PMID: 18031781 DOI: 10.1016/j.tice.2007.09.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
38 Brown LC, Petersen IA, Haddock MG, Bakkum-Gamez JN, Lee LJ, Cimbak NC, Berkowitz RS, Viswanathan AN. Vaginal brachytherapy for early-stage carcinosarcoma of the uterus. Brachytherapy 2015;14:433-9. [PMID: 25890795 DOI: 10.1016/j.brachy.2015.02.194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
39 Healy V, O'Halloran P, O'Brien S, Beausang A, Caird J. CNS metastasis secondary to malignant-mixed Müllerian tumor: case report and review of therapeutics. CNS Oncol 2017;6:315-23. [PMID: 28990810 DOI: 10.2217/cns-2017-0015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
40 Powell G, Barth L, Todd R, Ganesan R. Primary uterine osteosarcoma presenting synchronously with bilateral breast carcinomas. BMJ Case Rep 2014;2014:bcr2013201502. [PMID: 24898994 DOI: 10.1136/bcr-2013-201502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. J Natl Cancer Inst 2017;109:1-10. [PMID: 28376204 DOI: 10.1093/jnci/djw251] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
42 Versluis M, Plat A, de Bruyn M, Matias-Guiu X, Trovic J, Krakstad C, Nijman HW, Bosse T, de Bock GH, Hollema H. L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. Virchows Arch 2018;473:591-8. [PMID: 30140948 DOI: 10.1007/s00428-018-2444-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
43 Bloomston M, Chanona-vilchis J, Ellison EC, Ramirez NC, Frankel WL. Carcinosarcoma of the Pancreas Arising in a Mucinous Cystic Neoplasm. The American Surgeon 2006;72:351-5. [DOI: 10.1177/000313480607200416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
44 Dusenbery KE, Potish RA, Judson P. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus. Gynecologic Oncology 2004;94:191-6. [DOI: 10.1016/j.ygyno.2004.04.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
45 Giraudet G, Collinet P, Farine MO, Narducci F, Poncelet E, Baranzelli MC, Vinatier D. [Twenty-two cases of uterine carcinosarcomas]. J Gynecol Obstet Biol Reprod (Paris) 2011;40:22-8. [PMID: 21112160 DOI: 10.1016/j.jgyn.2010.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Mount SL, Cooper K. Tumours with divergent müllerian differentiation of the uterine corpus. Current Diagnostic Pathology 2005;11:349-55. [DOI: 10.1016/j.cdip.2005.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
47 Lin Y, Wang T, Lin J, Wang H-, Chou K, Shih S, Chen M. Hepatic carcinosarcoma: clinicopathologic features and a review of the literature. Annals of Hepatology 2013;12:495-500. [DOI: 10.1016/s1665-2681(19)31015-4] [Cited by in Crossref: 14] [Article Influence: 1.6] [Reference Citation Analysis]
48 Diver EJ, Foster R, Rueda BR, Growdon WB. The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer. Oncologist 2015;20:1058-68. [PMID: 26099744 DOI: 10.1634/theoncologist.2015-0149] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
49 Chiyoda T, Tsuda H, Tanaka H, Kataoka F, Nomura H, Nishimura S, Takano M, Susumu N, Saya H, Aoki D. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma? Genes Chromosomes Cancer 2012;51:229-39. [PMID: 22072501 DOI: 10.1002/gcc.20947] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
50 Pazzini R, Pereira GA, Macarenco RS. Cutaneous Metaplastic Carcinoma: Report of a Case With Sebaceous Differentiation. Am J Dermatopathol 2018;40:e100-3. [PMID: 29293124 DOI: 10.1097/DAD.0000000000001070] [Reference Citation Analysis]
51 Leung F, Terzibachian JJ, Govyadovskiy A, Bourtembourg A, Maillet R, Riethmuller D. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma]. Gynecol Obstet Fertil 2009;37:447-51. [PMID: 19394886 DOI: 10.1016/j.gyobfe.2009.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
52 Bigby SM, Eva LJ, Jones RW. Spindle Cell Carcinoma of the Vulva: A Series of 4 Cases and Review of the Literature. International Journal of Gynecological Pathology 2014;33:203-12. [DOI: 10.1097/pgp.0b013e31828bb49d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
53 Salibay CJ, Rewerska J, Gupta S, Ree N. Primary Carcinosarcoma of the Pancreas With CD10-Positive Sarcoma Component. J Investig Med High Impact Case Rep 2017;5:2324709617740906. [PMID: 29152519 DOI: 10.1177/2324709617740906] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Antuofermo E, Cocco R, Borzacchiello G, Burrai GP, Meloni F, Bonelli P, Pirino S, Cossu-Rocca P, Bosincu L. Bilateral ovarian malignant mixed Mullerian tumor in a dog. Vet Pathol 2009;46:453-6. [PMID: 19176505 DOI: 10.1354/vp.08-VP-0151-A-BC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
55 Lopez-garcia M, Palacios J. Pathologic and molecular features of uterine carcinosarcomas. Seminars in Diagnostic Pathology 2010;27:274-86. [DOI: 10.1053/j.semdp.2010.09.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
56 Barker HE, Scott CL. Genomics of gynaecological carcinosarcomas and future treatment options. Semin Cancer Biol 2020;61:110-20. [PMID: 31622660 DOI: 10.1016/j.semcancer.2019.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Joshi CV, Enver T. Plasticity revisited. Current Opinion in Cell Biology 2002;14:749-55. [DOI: 10.1016/s0955-0674(02)00392-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
58 Yamamoto R, Suzuki K, Uchida K, Onda N, Shibutani M, Mitsumori K. Pancreatic carcinosarcoma in a cat. J Comp Pathol 2012;147:223-6. [PMID: 22520812 DOI: 10.1016/j.jcpa.2012.01.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
59 Shigeta S, Nagase S, Mikami M, Ikeda M, Shida M, Sakaguchi I, Ushioda N, Takahashi F, Yamagami W, Yaegashi N, Udagawa Y, Katabuchi H. Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee. J Gynecol Oncol 2017;28:e76. [PMID: 29027394 DOI: 10.3802/jgo.2017.28.e76] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
60 Cabibi D, Martorana A, Cappello F, Barresi E, Di Gangi C, Rodolico V. Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report. BMC Cancer 2006;6:47. [PMID: 16509974 DOI: 10.1186/1471-2407-6-47] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
61 Akahira J, Tokunaga H, Toyoshima M, Takano T, Nagase S, Yoshinaga K, Tase T, Wada Y, Ito K, Niikura H, Yamada H, Sato A, Sasano H, Yaegashi N. Prognoses and Prognostic Factors of Carcinosarcoma, Endometrial Stromal Sarcoma and Uterine Leiomyosarcoma: A Comparison with Uterine Endometrial Adenocarcinoma. Oncology 2007;71:333-40. [DOI: 10.1159/000107107] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
62 Zhang X, Bai Q, Xu Y, Wang W, Chen L, Han J, Zhu H, Zhang Z, Hou Y, Zhou J, Zhou Y, Ji Y. Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing. Histopathology. 2019;74:944-958. [PMID: 30629754 DOI: 10.1111/his.13822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
63 Adam P, Zettl A, Zollner U, Dietl J, Müller-hermelink HK, Eck M. Metastasizing vulvar carcinosarcoma with squamous carcinomatous and leiomyosarcomatous differentiation: genetic evidence of clonal origin. Human Pathology 2005;36:1143-7. [DOI: 10.1016/j.humpath.2005.07.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
64 Oʼmeara AT. Uterine sarcomas: have we made any progress?: . Current Opinion in Obstetrics and Gynecology 2004;16:1-4. [DOI: 10.1097/00001703-200402000-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
65 English DP, Roque DM, Santin AD. HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies. Mol Diagn Ther. 2013;17:85-99. [PMID: 23529353 DOI: 10.1007/s40291-013-0024-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 108] [Article Influence: 12.6] [Reference Citation Analysis]
66 Growdon WB, Roussel BN, Scialabba VL, Foster R, Dias-santagata D, Iafrate AJ, Ellisen LW, Tambouret RH, Rueda BR, Borger DR. Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin. Gynecologic Oncology 2011;121:212-7. [DOI: 10.1016/j.ygyno.2010.11.039] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
67 Osakabe M, Fukagawa D, Sato C, Sugimoto R, Uesugi N, Ishida K, Itamochi H, Sugiyama T, Sugai T. Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma. Int J Gynecol Cancer 2019;29:277-81. [PMID: 30636710 DOI: 10.1136/ijgc-2018-000038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Rajshekar SK, Guruprasad B, Shakunthala P, Rathod P, Devi U, Bafna U. Malignant mixed Mullerian tumour of the uterus. Ecancermedicalscience. 2013;7:302. [PMID: 23589731 DOI: 10.3332/ecancer.2013.302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Schipf A, Mayr D, Kirchner T, Diebold J. Molecular genetic aberrations of ovarian and uterine carcinosarcomas—a CGH and FISH study. Virchows Arch 2008;452:259-68. [DOI: 10.1007/s00428-007-0557-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
70 Dunnick JK, Sanders JM, Kissling GE, Johnson CL, Boyle MH, Elmore SA. Environmental chemical exposure may contribute to uterine cancer development: studies with tetrabromobisphenol A. Toxicol Pathol 2015;43:464-73. [PMID: 25476797 DOI: 10.1177/0192623314557335] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
71 Kazakov DV, Vittay G, Michal M, Calonje E. High-grade Trichoblastic Carcinosarcoma. The American Journal of Dermatopathology 2008;30:62-4. [DOI: 10.1097/dad.0b013e31815c6c7f] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
72 Abdulfatah E, Lordello L, Khurram M, Van de Vijver K, Alosh B, Bandyopadhyay S, Oliva E, Ali-Fehmi R. Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study. Int J Gynecol Pathol 2019;38:205-15. [PMID: 30958427 DOI: 10.1097/PGP.0000000000000497] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
73 Liu Y, Hao H, Guo X, Xu J, Kang L, Zheng G, Zhao H. Rare pancreatic carcinosarcoma in a patient with medical history of esophageal cancer: A case report and literature review. Medicine (Baltimore). 2019;98:e15238. [PMID: 31008956 DOI: 10.1097/md.0000000000015238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
74 Schulten HJ, Wolf-Salgó J, Gründker C, Gunawan B, Füzesi L. Characterization of a newly established uterine carcinosarcoma cell line featuring the sarcomatous phenotype of the tumor in vitro. Int J Gynecol Cancer 2008;18:339-44. [PMID: 18334012 DOI: 10.1111/j.1525-1438.2007.01004.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
75 Casali PG, Sanfilippo R, D'incalci M. Trabectedin therapy for sarcomas. Current Opinion in Oncology 2010;22:342-6. [DOI: 10.1097/cco.0b013e32833aaac1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
76 Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, Black J, Cocco E, Choi J, Zammataro L, Predolini F, Bonazzoli E, Bi M, Buza N, Hui P, Wong S, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Facchetti F, Falchetti M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Mane S, Angioli R, Terranova C, Quick CM, Edraki B, Bilgüvar K, Lee M, Choi M, Stiegler AL, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 2016;113:12238-43. [PMID: 27791010 DOI: 10.1073/pnas.1614120113] [Cited by in Crossref: 109] [Cited by in F6Publishing: 97] [Article Influence: 18.2] [Reference Citation Analysis]
77 D'Angelo E, Prat J. Pathology of mixed Müllerian tumours. Best Pract Res Clin Obstet Gynaecol 2011;25:705-18. [PMID: 21742560 DOI: 10.1016/j.bpobgyn.2011.05.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
78 Kumar M, Goel MM, Das V. Bilateral ovarian malignant mixed Mullerian tumour: a rare entity. BMJ Case Rep 2013;2013:bcr2013009495. [PMID: 23988818 DOI: 10.1136/bcr-2013-009495] [Reference Citation Analysis]
79 Tsuyama S, Saito T, Akazawa Y, Yanai Y, Yatagai N, Akaike K, Hayashi T, Suehara Y, Takahashi F, Takamochi K, Hashimoto T, Kajiyama Y, Tsurumaru M, Fukunaga T, Yao T. Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change. Virchows Arch. 2019;475:415-424. [PMID: 31444625 DOI: 10.1007/s00428-019-02643-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
80 Ferrandina G, Zannoni G, Martinelli E, Vellone V, Prisco M, Scambia G. Endometrial carcinoma recurring as carcinosarcoma: Report of two cases. Pathology - Research and Practice 2007;203:677-81. [DOI: 10.1016/j.prp.2007.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
81 Keeling L, Taraporewalla D, Perunovic B, Smith JH. Uterine carcinosarcoma with p53-positive intraepithelial component. Histopathology 2011;59:1277-8. [PMID: 22026369 DOI: 10.1111/j.1365-2559.2011.03996.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
82 Babu R S A, Reddy B V R, C H A. Histogenetic concepts, terminology and categorization of biphasic tumours of the oral and maxillofacial region. J Clin Diagn Res 2014;8:266-70. [PMID: 24701553 DOI: 10.7860/JCDR/2014/7506.4078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 Oliva E. Pure Mesenchymal and Mixed Müllerian Tumors of the Uterus. Gynecologic Pathology. Elsevier; 2009. pp. 261-329. [DOI: 10.1016/b978-044306920-8.50012-2] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
84 Pelosi G, Scarpa A, Manzotti M, Veronesi G, Spaggiari L, Fraggetta F, Nappi O, Benini E, Pasini F, Antonello D, Iannucci A, Maisonneuve P, Viale G. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol 2004;17:538-46. [PMID: 14990969 DOI: 10.1038/modpathol.3800058] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
85 Cossic B, Hill JA, Cercone M, Southard T. Uterine carcinosarcoma (malignant mixed Müllerian tumor): case report in a goat and literature review. J Vet Diagn Invest 2018;30:955-61. [PMID: 30345891 DOI: 10.1177/1040638718808341] [Reference Citation Analysis]
86 Inoue H, Hashimura M, Akiya M, Chiba R, Saegusa M. Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma. Mol Cancer 2017;16:37. [PMID: 28193280 DOI: 10.1186/s12943-017-0609-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
87 Ardighieri L, Mori L, Conzadori S, Bugatti M, Falchetti M, Donzelli CM, Ravaggi A, Odicino FE, Facchetti F. Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship. Virchows Arch 2016;469:61-9. [PMID: 27059324 DOI: 10.1007/s00428-016-1933-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
88 Yoshida A, Sen C, Asa SL, Rosenblum MK. Composite pituitary adenoma and craniopharyngioma?: an unusual sellar neoplasm with divergent differentiation. Am J Surg Pathol 2008;32:1736-41. [PMID: 18769335 DOI: 10.1097/PAS.0b013e3181753abd] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
89 Gotoh O, Sugiyama Y, Takazawa Y, Kato K, Tanaka N, Omatsu K, Takeshima N, Nomura H, Hasegawa K, Fujiwara K, Taki M, Matsumura N, Noda T, Mori S. Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma. Nat Commun 2019;10:4965. [PMID: 31672974 DOI: 10.1038/s41467-019-12985-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
90 Brown L. Pathology of uterine malignancies. Clin Oncol (R Coll Radiol) 2008;20:433-47. [PMID: 18499412 DOI: 10.1016/j.clon.2008.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
91 McCluggage WG. A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus. Mod Pathol 2016;29 Suppl 1:S78-91. [PMID: 26715175 DOI: 10.1038/modpathol.2015.137] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
92 Pelosi G, Sonzogni A, De Pas T, Galetta D, Veronesi G, Spaggiari L, Manzotti M, Fumagalli C, Bresaola E, Nappi O. Review article: pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol. 2010;18:103-120. [PMID: 19124452 DOI: 10.1177/1066896908330049] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 6.9] [Reference Citation Analysis]
93 Kurshumliu F, Rung-Hansen H, Skovlund VR, Gashi-Luci L, Horn T. Primary malignant mixed müllerian tumor of the peritoneum a case report with review of the literature. World J Surg Oncol 2011;9:17. [PMID: 21294883 DOI: 10.1186/1477-7819-9-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
94 Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist. 2008;13 Suppl 2:4-7. [PMID: 18434631 DOI: 10.1634/theoncologist.13-s2-4] [Cited by in Crossref: 163] [Cited by in F6Publishing: 58] [Article Influence: 11.6] [Reference Citation Analysis]
95 Lee SJ, Choi YL, Lee EJ, Kim BG, Bae DS, Ahn GH, Lee JH. Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis. Int J Gynecol Cancer 2007;17:248-53. [PMID: 17291261 DOI: 10.1111/j.1525-1438.2006.00756.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
96 Horn LC, Schierle K, Schmidt D, Ulrich U, Liebmann A, Wittekind C. [Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background]. Pathologe 2011;32:239-43. [PMID: 20084383 DOI: 10.1007/s00292-010-1273-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
97 Aghajanian C, Sill MW, Secord AA, Powell MA, Steinhoff M. Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 2012;126:424-427. [PMID: 22634397 DOI: 10.1016/j.ygyno.2012.05.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
98 Chen H, He Y, Wen X, Shao S, Liu Y, Wang J. SOX9: Advances in Gynecological Malignancies. Front Oncol 2021;11:768264. [PMID: 34881182 DOI: 10.3389/fonc.2021.768264] [Reference Citation Analysis]
99 Bourgeault E, Alain J, Gagné E. Primary Cutaneous Carcinosarcoma of the Basal Cell Subtype Should Be Treated as a High-Risk Basal Cell Carcinoma. J Cutan Med Surg 2015;19:407-11. [PMID: 25775619 DOI: 10.1177/1203475415575233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
100 Mano MS, Rosa DD, Azambuja E, Ismael G, Braga S, D'Hondt V, Piccart M, Awada A. Current management of ovarian carcinosarcoma. Int J Gynecol Cancer 2007;17:316-24. [PMID: 17362309 DOI: 10.1111/j.1525-1438.2006.00760.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
101 Shaco-Levy R, Piura B. Endometrioid endometrial adenocarcinoma recurring as carcinosarcoma. J Obstet Gynaecol Res 2008;34:279-82. [PMID: 18412798 DOI: 10.1111/j.1447-0756.2008.00771.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
102 D'Angelo E, Prat J. Diagnostic use of immunohistochemistry in uterine mesenchymal tumors. Semin Diagn Pathol 2014;31:216-22. [PMID: 24863031 DOI: 10.1053/j.semdp.2014.03.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
103 Bhattacharjee P, Leffell D, Mcniff JM. Primary cutaneous carcinosarcoma arising in a patient with nevoid basal cell carcinoma syndrome. J Cutan Pathol 2005;32:638-41. [DOI: 10.1111/j.0303-6987.2005.00384.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
104 Hacking S, Chavarria H, Jin C, Perry A, Nasim M. Landscape of Immune Checkpoint Inhibition in Carcinosarcoma (MMMT): Analysis of IDO-1, PD-L1 and PD-1. Pathol Res Pract 2020;216:152847. [PMID: 32085927 DOI: 10.1016/j.prp.2020.152847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
105 Park HJ, Kim HJ, Wu HG, Kim H, Ha SW, Kang SB, Song YS, Park NH, Kim JW. The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma. Radiat Oncol J 2011;29:228-35. [PMID: 22984675 DOI: 10.3857/roj.2011.29.4.228] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
106 Kajo K, Zubor P, Spacek J, Ryska A. Carcinosarcoma of the uterus with melanocytic differentiation. Pathology - Research and Practice 2007;203:753-8. [DOI: 10.1016/j.prp.2007.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
107 Tan KB, Premasiri MK, Putti TC. Uterine malignant mixed müllerian tumour with pilomatrixoma-like areas. Pathology 2003;35:532-3. [PMID: 14660107 DOI: 10.1080/00313020310001619208] [Reference Citation Analysis]
108 Tokar EJ, Diwan BA, Waalkes MP. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ Health Perspect. 2010;118:108-115. [PMID: 20056578 DOI: 10.1289/ehp.0901059] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 9.3] [Reference Citation Analysis]
109 Bai Q, Zhang X, Zhu X, Wang L, Huang D, Cai X, Zhou X, Wang J, Sheng W. Pancreatic carcinosarcoma with the same KRAS gene mutation in both carcinomatous and sarcomatous components: molecular evidence for monoclonal origin of the tumour. Histopathology 2016;69:393-405. [PMID: 27307095 DOI: 10.1111/his.12975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
110 Karpowicz MK, Shalmon B, Molberg KH, El-Naggar AK. Melanoma in a carcinoma ex pleomorphic adenoma of the parotid gland: a case report and putative histogenesis. Hum Pathol 2011;42:1355-8. [PMID: 21411120 DOI: 10.1016/j.humpath.2010.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
111 Rose RF, Merchant W, Stables GI, Lyon CL, Platt A. Basal cell carcinoma with a sarcomatous component (carcinosarcoma): A series of 5 cases and a review of the literature. Journal of the American Academy of Dermatology 2008;59:627-32. [DOI: 10.1016/j.jaad.2008.05.035] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
112 Hensley ML. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas. Best Practice & Research Clinical Obstetrics & Gynaecology 2011;25:773-82. [DOI: 10.1016/j.bpobgyn.2011.06.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
113 Raspollini MR, Taddei GL, Marchionni M, Bacci S, Romagnoli P. Differential Diagnosis between Uterine Carcinosarcoma versus Carcinoma with Sarcomatous Metaplasia: An Immunohistochemical and Ultrastructural Case Study. Ultrastructural Pathology 2009;29:149-55. [DOI: 10.1080/019131290924072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
114 Pelosi G, Sonzogni A, Viale G. The Classification of Lung Carcinoma: Time to Change the Morphology-Based Approach? Int J Surg Pathol 2010;18:161-72. [DOI: 10.1177/1066896910361736] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
115 Schwartz TL, Mogal H, Papageorgiou C, Veerapong J, Hsueh EC. Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies. Exp Hematol Oncol 2013;2:31. [PMID: 24499560 DOI: 10.1186/2162-3619-2-31] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
116 Reed N. The Management of Uterine Sarcomas. Clinical Oncology 2008;20:470-8. [DOI: 10.1016/j.clon.2008.04.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
117 Mete Ö, Özbey N, Erbil Y, Salmaslıoglu A, Aral F, Temel B, Dizdaroglu F. Thyroid metastasis of endometrial carcinosarcoma associated with Graves' disease. Gynecological Endocrinology 2009;23:562-6. [DOI: 10.1080/09513590701560733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
118 Mccluggage WG, Robboy SJ. Mesenchymal uterine tumors, other than pure smooth muscle neoplasms, and adenomyosis. Robboy's Pathology of the Female Reproductive Tract. Elsevier; 2009. pp. 427-56. [DOI: 10.1016/b978-0-443-07477-6.50022-6] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
119 Horn LC, Beckmann MW, Beller A, Schmidt D, Ulrich U, Hantschmann P, Wittekind C. [Changes in the TNM classification of gynecological tumors]. Pathologe 2010;31:367-73. [PMID: 20844876 DOI: 10.1007/s00292-010-1308-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
120 Guy JB, Trone JC, Casteillo F, Forest F, Pacaut C, Moncharmont C, Espenel S, Vallard A, Langrand Escure J, Collard O, Peoc'h M, Magné N. [Carcinosarcomas in female genital tracts: general review]. Bull Cancer 2014;101:760-4. [PMID: 25091658 DOI: 10.1684/bdc.2014.1937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
121 Shen ZL, Wang S, Ye YJ, Wang YL, Sun KK, Yang XD, Jiang KW. Carcinosarcoma of pancreas with liver metastasis combined with gastrointestinal stromal tumour of the stomach: is there a good prognosis with the complete resection? Eur J Cancer Care (Engl). 2010;19:118-123. [PMID: 19486125 DOI: 10.1111/j.1365-2354.2008.00977.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
122 Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA. Prognostic Features of Surgical Stage I Uterine Carcinosarcoma. American Journal of Surgical Pathology 2007;31:1653-61. [DOI: 10.1097/pas.0b013e3181161ba3] [Cited by in Crossref: 119] [Cited by in F6Publishing: 31] [Article Influence: 7.9] [Reference Citation Analysis]
123 Nicoletti R, Lopez S, Bellone S, Cocco E, Schwab CL, Black JD, Centritto F, Zhu L, Bonazzoli E, Buza N, Hui P, Mezzanzanica D, Canevari S, Schwartz PE, Rutherford TJ, Santin AD. T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2. Clin Exp Metastasis 2015;32:29-38. [PMID: 25398397 DOI: 10.1007/s10585-014-9688-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
124 Sleijfer S, Seynaeve C, Verweij J. Gynaecological sarcomas. Current Opinion in Oncology 2007;19:492-6. [DOI: 10.1097/cco.0b013e3282748eaa] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
125 Stewart CJ, McCluggage WG. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology 2013;62:31-43. [PMID: 23240668 DOI: 10.1111/his.12057] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
126 Cui RR, Wright JD, Hou JY. Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome. BJOG 2017;124:1028-37. [PMID: 28128524 DOI: 10.1111/1471-0528.14579] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
127 Tanveer N, Gupta B, Pathre A, Rajaram S, Goyal N. A Rare Collision Tumour of Uterus- Squamous Cell Carcinoma and Endometrial Stromal Sarcoma. J Clin Diagn Res 2017;11:ED20-2. [PMID: 28384878 DOI: 10.7860/JCDR/2017/23532.9405] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
128 del Carmen MG, Birrer M, Schorge JO. Carcinosarcoma of the ovary: A review of the literature. Gynecologic Oncology 2012;125:271-7. [DOI: 10.1016/j.ygyno.2011.12.418] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
129 Sohaib SA, Verma H, Attygalle AD, Ind TE. Imaging of Uterine Malignancies. Seminars in Ultrasound, CT and MRI 2010;31:377-87. [DOI: 10.1053/j.sult.2010.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
130 Ruess DA, Kayser C, Neubauer J, Fichtner-Feigl S, Hopt UT, Wittel UA. Carcinosarcoma of the Pancreas: Case Report With Comprehensive Literature Review. Pancreas. 2017;46:1225-1233. [PMID: 28902796 DOI: 10.1097/mpa.0000000000000904] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
131 Yoshida T, Hashimura M, Kuwata T, Matsumoto T, Suzuki E, Tazo Y, Nakajima H, Inukai M, Saegusa M. Transcriptional regulation of the alpha-1 type II collagen gene by nuclear factor B/p65 and Sox9 in the chondrocytic phenotype of uterine carcinosarcomas. Hum Pathol 2013;44:1780-8. [PMID: 23618358 DOI: 10.1016/j.humpath.2012.12.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
132 Quadri AM, Ganesan R, Hock YL, Karim SN, Hirschowitz L. Malignant Transformation in Mature Cystic Teratoma of the Ovary: Three Cases Mimicking Primary Ovarian Epithelial Tumors. Int J Surg Pathol 2011;19:718-23. [DOI: 10.1177/1066896909353601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
133 Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, Vecchini G, Arapantoni-Dadioti P, Kaldrymides P. Thyroid carcinosarcoma in a patient with lung carcinoma. J Clin Oncol 2010;28:e663-4. [PMID: 20823405 DOI: 10.1200/JCO.2010.29.6772] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 Lao XM, Chen DY, Zhang YQ, Xiang J, Guo RP, Lin XJ, Li JQ. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature. Am J Surg Pathol 2007;31:817-26. [PMID: 17527068 DOI: 10.1097/01.pas.0000213431.07116.e0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
135 McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer. 2002;12:687-690. [PMID: 12445244 DOI: 10.1046/j.1525-1438.2002.01151.x] [Cited by in Crossref: 156] [Cited by in F6Publishing: 146] [Article Influence: 8.2] [Reference Citation Analysis]
136 Tochimoto M, Oguri Y, Hashimura M, Konno R, Matsumoto T, Yokoi A, Kodera Y, Saegusa M. S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma. Lab Invest 2020;100:682-95. [PMID: 31857700 DOI: 10.1038/s41374-019-0359-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
137 Kostov S, Kornovski Y, Ivanova Y, Dzhenkov D, Stoyanov G, Stoilov S, Slavchev S, Trendafilova E, Yordanov A. Ovarian Carcinosarcoma with Retroperitoneal Para-Aortic Lymph Node Dissemination Followed by an Unusual Postoperative Complication: A Case Report with a Brief Literature Review. Diagnostics (Basel) 2020;10:E1073. [PMID: 33322259 DOI: 10.3390/diagnostics10121073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Kwon D, Ronen S, Giubellino A, Keiser E, Aung PP, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition. J Cutan Pathol 2021;48:526-34. [PMID: 32564423 DOI: 10.1111/cup.13782] [Reference Citation Analysis]
139 Brasanac D, Boricic I, Todorovic V, Tomanovic N. Primary cutaneous carcinosarcoma: case report with expanded immunohistochemical analysis. Int J Dermatol 2008;47:496-501. [DOI: 10.1111/j.1365-4632.2008.03427.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
140 Ozolek JA, Finkelstein SD, Couce ME. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol 2004;17:739-45. [PMID: 15148503 DOI: 10.1038/modpathol.3800109] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
141 Odei B, Boothe D, Suneja G, Werner TL, Gaffney DK. Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. American Journal of Clinical Oncology 2018;41:784-91. [DOI: 10.1097/coc.0000000000000360] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
142 Sawada M, Tsuda H, Kimura M, Okamoto S, Kita T, Kasamatsu T, Yamada T, Kikuchi Y, Honjo H, Matsubara O. Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma. Cancer Sci 2003;94:986-91. [PMID: 14611676 DOI: 10.1111/j.1349-7006.2003.tb01389.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
143 Mszyco S, Teng L, Annunziata J, Hartman MS. Pancreatic Carcinosarcoma: A Case Report Highlighting Computed Tomography Characteristics. Curr Probl Diagn Radiol. 2017;46:342-345. [PMID: 28318763 DOI: 10.1067/j.cpradiol.2017.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
144 Del Papa M, D'Amata G, Manzi F, Musmeci L, Crovaro M, Buonocore C, Florio G, Giannetti A. Extragenital malignant mixed mesodermal tumor: A case report. Int J Surg Case Rep 2017;41:323-6. [PMID: 29136604 DOI: 10.1016/j.ijscr.2017.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
145 Thankamony AP, Subbalakshmi AR, Jolly MK, Nair R. Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers (Basel) 2021;13:3602. [PMID: 34298815 DOI: 10.3390/cancers13143602] [Reference Citation Analysis]
146 Mcgee J, Bookman M, Harter P, Marth C, Mcneish I, Moore K, Poveda A, Hilpert F, Hasegawa K, Bacon M, Gatsonis C, Brand A, Kridelka F, Berek J, Ottevanger N, Levy T, Silverberg S, Kim B, Hirte H, Okamoto A, Stuart G, Ochiai K. Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors. Annals of Oncology 2017;28:702-10. [DOI: 10.1093/annonc/mdx010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
147 Kantrow SM, Boyd AS. Primary Cutaneous Metaplastic Carcinoma: Report of a Case Involving Angiosarcoma. The American Journal of Dermatopathology 2007;29:270-3. [DOI: 10.1097/dad.0b013e3180332b53] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
148 McCluggage WG. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology. 2011;43:420-432. [PMID: 21716157 DOI: 10.1097/pat.0b013e328348a6e7] [Cited by in Crossref: 265] [Cited by in F6Publishing: 137] [Article Influence: 24.1] [Reference Citation Analysis]
149 Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 2019;79:1043-60. [PMID: 31656317 DOI: 10.1055/a-0882-4116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
150 Ritterhouse LL, Howitt BE. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors. Surg Pathol Clin 2016;9:405-26. [PMID: 27523969 DOI: 10.1016/j.path.2016.04.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
151 Cui T, Jin Y, Li B, Li J, Yue Y. Dynamic contrast-enhanced MR and PET/CT findings of uterine sarcomatoid carcinoma: a case report. BMC Womens Health 2020;20:223. [PMID: 33023546 DOI: 10.1186/s12905-020-01084-5] [Reference Citation Analysis]
152 Voutsadakis IA. Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities. Clin Transl Oncol. 2012;14:243-253. [PMID: 22484631 DOI: 10.1007/s12094-012-0792-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
153 Mccluggage WG, Judge MJ, Clarke BA, Davidson B, Gilks CB, Hollema H, Ledermann JA, Matias-guiu X, Mikami Y, Stewart CJ, Vang R, Hirschowitz L. Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol 2015;28:1101-22. [DOI: 10.1038/modpathol.2015.77] [Cited by in Crossref: 109] [Cited by in F6Publishing: 89] [Article Influence: 15.6] [Reference Citation Analysis]
154 Jones TE, Pradhan D, Dabbs DJ, Bhargava R, Onisko A, Jones MW. Immunohistochemical Markers With Potential Diagnostic, Prognostic, and Therapeutic Significance in Uterine Carcinosarcoma: A Clinicopathologic Study of 43 Cases. Int J Gynecol Pathol 2021;40:84-93. [PMID: 31855950 DOI: 10.1097/PGP.0000000000000662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
155 Jenkins TM, Hanley KZ, Schwartz LE, Cantrell LA, Stoler MH, Mills AM. Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Multi-institution Retrospective Review. Am J Surg Pathol 2020;44:782-92. [PMID: 31934920 DOI: 10.1097/PAS.0000000000001434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
156 Soslow RA. Uterine mesenchymal tumors: a review of selected topics. Diagnostic Histopathology 2008;14:175-88. [DOI: 10.1016/j.mpdhp.2008.02.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
157 El Harroudi T, Ech-Charif S, Amrani M, Jalil A. Primary carcinosarcoma of the skin. J Hand Microsurg 2010;2:79-81. [PMID: 22282673 DOI: 10.1007/s12593-010-0013-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
158 McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 2006;59:801-12. [PMID: 16873562 DOI: 10.1136/jcp.2005.029702] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
159 Ruiz Tovar J, Reguero Callejas ME, Arano Bermejo JI, Capote Armas LF, González-Palacios Martínez F, Cabañas Navarro L. Malignant mixed Mullerian tumors. Clin Transl Oncol 2006;8:129-32. [PMID: 16632428 DOI: 10.1007/s12094-006-0170-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
160 Horn LC, Schmidt D, Fathke C, Ulrich U; Mitglieder der Organgruppe Uterus der AGO. [New FIGO staging for uterine sarcomas]. Pathologe 2009;30:302-3. [PMID: 19513716 DOI: 10.1007/s00292-009-1158-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
161 Miller BE, Blessing JA, Stehman FB, Shahin MS, Yamada SD, Secord AA, Warshal DP, Abulafia O, Richards WE, Van Le L. A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: A gynecologic oncology group study. Gynecologic Oncology 2010;118:139-44. [DOI: 10.1016/j.ygyno.2010.03.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
162 Gründker C, Günthert AR, Emons G. Hormonal heterogeneity of endometrial cancer. Adv Exp Med Biol 2008;630:166-88. [PMID: 18637491 DOI: 10.1007/978-0-387-78818-0_11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
163 Bigby SM, Charlton A, Miller MV, Zwi LJ, Oliver GF. Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature. J Cutan Pathol 2005;32:141-7. [DOI: 10.1111/j.0303-6987.2005.00276.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
164 De Francesco V, Frattasio A, Pillon B, Stinco G, Scott CA, Trotter D, Patrone P. Carcinosarcoma Arising in a Patient with Multiple Cylindromas: . The American Journal of Dermatopathology 2005;27:21-6. [DOI: 10.1097/01.dad.0000141548.69423.c7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
165 Setia A, Kumar D, Bains L, Sharma P, Tempe A, Mallya V. Renal Hemangioblastoma with Mixed Mullerian tumour of endometrium: A tale of two rare primary tumours. World J Surg Oncol 2020;18:154. [PMID: 32631354 DOI: 10.1186/s12957-020-01929-1] [Reference Citation Analysis]
166 Mccluggage WG. Benign Diseases of the Endometrium. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s Pathology of the Female Genital Tract. Boston: Springer US; 2011. pp. 305-58. [DOI: 10.1007/978-1-4419-0489-8_7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
167 van den Brink-Knol H, van Esch E. Spontaneous malignant mixed Müllerian tumor in a Wistar rat: a case report including immunohistochemistry. Vet Pathol 2010;47:1105-10. [PMID: 20587687 DOI: 10.1177/0300985810374840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
168 Meseci E, Naki MM. Prognostic factors, survival outcomes, and surgical practices when dealing with uterine sarcomas: 8 years’ clinical experience. J Turk Ger Gynecol Assoc 2019;20:154-64. [PMID: 31298514 DOI: 10.4274/jtgga.galenos.2019.2019.0061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
169 Soslow RA. Mixed Müllerian Tumors of the Female Genital Tract. Surg Pathol Clin 2009;2:707-30. [PMID: 26838776 DOI: 10.1016/j.path.2009.08.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
170 Tsuji K, Ito A, Kurokawa S, Nakaya T, Yoshimoto T, Kawata H, Tamba-Sakaguchi M, Fukushima N, Oshiro H. Primary carcinosarcoma of the ureteropelvic junction associated with ureteral duplication: A case report. Medicine (Baltimore) 2019;98:e16643. [PMID: 31393362 DOI: 10.1097/MD.0000000000016643] [Reference Citation Analysis]
171 Tsekouras DK, Katsaragakis S, Theodorou D, Kafiri G, Archontovasilis F, Giannopoulos P, Drimousis P, Bramis J. Rectal carcinosarcoma: A case report and review of literature. World J Gastroenterol 2006; 12(9): 1481-1484 [PMID: 16552827 DOI: 10.3748/wjg.v12.i9.1481] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
172 Kokcu A, Celik H, Kefeli M, Yucel I. Co-existence of primary fallopian tube carcinoma and uterine carcinosarcoma. J Obstet Gynaecol 2014;34:750. [PMID: 24912001 DOI: 10.3109/01443615.2014.923817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
173 Leiser AL, Chi DS, Ishill NM, Tew WP. Carcinosarcoma of the ovary treated with platinum and taxane: The memorial Sloan-Kettering Cancer Center experience. Gynecologic Oncology 2007;105:657-61. [DOI: 10.1016/j.ygyno.2007.01.037] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
174 Gore CR, Patvekar MM, Kurade SJ, Kumar H, Pagaro PM. Malignant mixed mullerian tumor of the ovary. J Obstet Gynaecol India 2014;64:62-4. [PMID: 25404814 DOI: 10.1007/s13224-012-0284-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
175 Milne AN, Carvalho R, van Rees BP, van Lanschot JJ, Offerhaus GJ, Weterman MA. Do collision tumors of the gastroesophageal junction exist A molecular analysis. Am J Surg Pathol. 2004;28:1492-1498. [PMID: 15489653 DOI: 10.1097/01.pas.0000138184.74496.4d] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
176 Hong SH, Hong S, Lee Y, Kang E. Primary Cutaneous Carcinosarcoma of the Shoulder: Case Report with Literature Review. Dermatologic Surgery 2013;39:338-40. [DOI: 10.1111/dsu.12023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
177 Menderes G, Bonazzoli E, Bellone S, Black J, Predolini F, Pettinella F, Masserdotti A, Zammataro L, Altwerger G, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression. Clin Cancer Res 2017;23:5836-45. [PMID: 28679774 DOI: 10.1158/1078-0432.CCR-16-2862] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
178 Raspollini M, Susini T, Amunni G, Paglierani M, Castiglione F, Garbini F, Carriero C, Scarselli G, Taddei G. Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? Int J Gynecol Cancer 2006;16:416-22. [DOI: 10.1111/j.1525-1438.2006.00410.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
179 Hedrick Ellenson L, Ronnett BM, Soslow RA, Lastra RR, Kurman RJ. Endometrial Carcinoma. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 473-533. [DOI: 10.1007/978-3-319-46334-6_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
180 Goh SGN, Dayrit JF, Calonje E. Sarcomatoid eccrine porocarcinoma: report of two cases and a review of the literature. J Cutan Pathol 2007;34:55-60. [DOI: 10.1111/j.1600-0560.2006.00556.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
181 Busca A, Gulavita P, Parra-Herran C, Islam S. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus. Int J Gynecol Pathol 2018;37:372-8. [PMID: 28700435 DOI: 10.1097/PGP.0000000000000424] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
182 Verweij J. Other Endpoints in Screening Studies for Soft Tissue Sarcomas. The Oncol 2008;13:27-31. [DOI: 10.1634/theoncologist.13-s2-27] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
183 Felix AS, Stone RA, Bowser R, Chivukula M, Edwards RP, Weissfeld JL, Linkov F. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers. Int J Gynecol Cancer 2011;21:877-84. [PMID: 21666484 DOI: 10.1097/IGC.0b013e31821a62dd] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
184 dos Santos LA, Garg K, Diaz JP, Soslow RA, Hensley ML, Alektiar KM, Barakat RR, Leitao MM. Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma. Gynecologic Oncology 2011;121:319-22. [DOI: 10.1016/j.ygyno.2010.12.363] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
185 McCluggage WG. Immunohistochemical Markers of Value in the Diagnosis of Mesenchymal Lesions of the Female Genital Tract. Surg Pathol Clin 2009;2:785-811. [PMID: 26838779 DOI: 10.1016/j.path.2009.08.017] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
186 Shah SH, Jagannathan JP, Krajewski K, O'Regan KN, George S, Ramaiya NH. Uterine sarcomas: then and now. AJR Am J Roentgenol. 2012;199:213-223. [PMID: 22733915 DOI: 10.2214/ajr.11.7287] [Cited by in Crossref: 69] [Cited by in F6Publishing: 20] [Article Influence: 6.9] [Reference Citation Analysis]
187 Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P, Strauss HG, Ulrich U, Horn LC, Schmidt D, Vordermark D, Vogl T, Reichardt P, Gaß P, Gebhardt M, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd 2015;75:1028-42. [PMID: 26640293 DOI: 10.1055/s-0035-1558120] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
188 Horn L, Dallacker M, Bilek K. Karzinosarkome (maligne Müller-Mischtumoren) des Uterus: Morphologie, molekulare Pathogenese und morphologische Prognosefaktoren. Pathologe 2009;30:292-301. [DOI: 10.1007/s00292-009-1153-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
189 Takamatsu S, Matsumura N, Baba T, Mandai M, Mikami Y, Konishi I. Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component. J Obstet Gynaecol Res 2014;40:263-7. [PMID: 24033661 DOI: 10.1111/jog.12136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
190 Ellenson LH, Ronnett BM, Soslow RA, Zaino RJ, Kurman RJ. Endometrial Carcinoma. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s Pathology of the Female Genital Tract. Boston: Springer US; 2011. pp. 394-452. [DOI: 10.1007/978-1-4419-0489-8_9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
191 Syme-grant J, Syme-grant NJ, Motta L, Stevenson JH, Evans AT. Are primary cutaneous carcinisarcomas underdiagnosed? Five cases and a review of the literature. Journal of Plastic, Reconstructive & Aesthetic Surgery 2006;59:1402-8. [DOI: 10.1016/j.bjps.2005.12.057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
192 Kunc M, Gabrych A, Rekawiecki B, Gorczynski A, Franke S, Haybaeck J, Biernat W, Czapiewski P. MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation. Contemp Oncol (Pozn) 2019;23:202-7. [PMID: 31992951 DOI: 10.5114/wo.2019.89635] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
193 Morotti M, Soleymani Majd H, Casarin J, Alazzam M, Damato S. Histomolecular features of high-grade endometrial cancers. Minerva Med 2021;112:20-30. [PMID: 33104303 DOI: 10.23736/S0026-4806.20.07082-2] [Reference Citation Analysis]
194 Livasy CA, Reading FC, Moore DT, Boggess JF, Lininger RA. EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma. Gynecologic Oncology 2006;100:101-6. [DOI: 10.1016/j.ygyno.2005.07.124] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
195 Seddon BM, Davda R. Uterine sarcomas--recent progress and future challenges. Eur J Radiol 2011;78:30-40. [PMID: 21247711 DOI: 10.1016/j.ejrad.2010.12.057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
196 Wang X, Tangjitgamol S, Liu J, Kavanagh JJ. Response of recurrent uterine high-grade malignant mixed müllerian tumor to letrozole. Int J Gynecol Cancer 2005;15:1243-8. [PMID: 16343224 DOI: 10.1111/j.1525-1438.2005.00193.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
197 Antovska VS, Krstevska I, Trajanova M, Chelebieva J, Gosheva I, Zdravkovski P, Kostadinova-Kunovska S, Janevska V. Endometrioid Adenocarcinoma Arising in Adenomyoma in a Woman with a Genital Prolapse - Case Report. Open Access Maced J Med Sci 2018;6:1091-4. [PMID: 29983808 DOI: 10.3889/oamjms.2018.239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
198 Leung F, Terzibachian J, Aouar Z, Govyadovskiy A, Lassabe C. Sarcomes utérins : aspects cliniques et histopathologiques. À propos de 15 cas. Gynécologie Obstétrique & Fertilité 2008;36:628-35. [DOI: 10.1016/j.gyobfe.2008.03.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
199 Öztürk Ç, Çay T, Tetikkurt S, Kasımogullar EV, Karacan T. Case report of atypical endometrial stromal cells in an endometrial polyp and osteoclastic like giant cells in leiomyoma in the same patient: Is it a coincidence or is it a result of Tamoxifen treatment? Acta Biomed 2019;90:572-6. [PMID: 31910187 DOI: 10.23750/abm.v90i4.7746] [Reference Citation Analysis]